Department of Orthopaedics and Traumatology, The University of Hong Kong, Pokfulam, Hong Kong, China.
Biol Trace Elem Res. 2012 Jan;145(1):39-46. doi: 10.1007/s12011-011-9158-y. Epub 2011 Aug 4.
Strontium (Sr) ralenate is a new agent used for the prevention and treatment of osteoporosis. As a bone-seeking element, 98% of Sr is deposited in the bone and teeth after oral ingestion. However, the effect of Sr treatment on bone microarchitecture and bone nanomechanical properties remains unclear. In this study, 18 osteoporotic goats were divided into four groups according to the treatment regimen: control, calcium alone (Ca), calcium and Sr at 24 mg/kg (Ca + 24Sr), and calcium and Sr at 40 mg/kg (Ca + 40Sr). The effects of Sr administration on bone microarchitecture and nanomechanical properties of trabecular bones were analyzed with micro-CT and nanoindentation test, respectively. Serum Sr levels increased six- and tenfold in the Ca + 24Sr and Ca + 40Sr groups, respectively. Similarly, Sr in the bone increased four- and sixfold in these two groups. Sr administration significantly increased trabecular bone volume fraction, trabecular thickness, and double-labeled new bone area. Sr administration, however, did not significantly change the nanomechanical properties of trabecular bone (elastic modulus and hardness). The data suggested that Sr administration increased trabecular bone volume and improved the microarchitecture while maintaining the intrinsic tissue properties in the osteoporotic goat model.
锶雷酸根是一种用于预防和治疗骨质疏松症的新型药物。作为一种亲骨性元素,口服后 98%的锶沉积在骨骼和牙齿中。然而,锶治疗对骨微观结构和骨纳米力学性能的影响尚不清楚。本研究将 18 只骨质疏松症山羊根据治疗方案分为四组:对照组、单独补钙(Ca)组、补钙加 24mg/kg 锶(Ca+24Sr)组和补钙加 40mg/kg 锶(Ca+40Sr)组。分别采用 micro-CT 和纳米压痕试验分析锶给药对小梁骨微观结构和纳米力学性能的影响。Ca+24Sr 和 Ca+40Sr 组血清锶水平分别升高了六倍和十倍,骨中的锶也分别升高了四倍和六倍。锶给药显著增加了小梁骨体积分数、小梁厚度和双标记新骨面积。然而,锶给药并未显著改变小梁骨的纳米力学性能(弹性模量和硬度)。数据表明,锶给药增加了小梁骨体积,改善了微观结构,同时维持了骨质疏松症山羊模型中组织的固有特性。